Bioceres Crop Solutions (NASDAQ:BIOX) Price Target Cut to $2.00 by Analysts at Canaccord Genuity Group

Bioceres Crop Solutions (NASDAQ:BIOX) had its price objective lowered by Canaccord Genuity Group from $2.25 to $2.00 in a research report released on Friday morning,Benzinga reports. Canaccord Genuity Group currently has a hold rating on the stock.

Several other equities analysts have also recently commented on the stock. Wall Street Zen raised shares of Bioceres Crop Solutions from a “sell” rating to a “hold” rating in a research note on Saturday, November 22nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a report on Monday. Lake Street Capital dropped their target price on Bioceres Crop Solutions from $8.00 to $5.00 and set a “buy” rating on the stock in a report on Wednesday, September 10th. Finally, Oppenheimer downgraded Bioceres Crop Solutions from an “outperform” rating to a “market perform” rating in a research report on Wednesday, October 22nd. One investment analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $4.00.

Bioceres Crop Solutions Price Performance

Shares of NASDAQ:BIOX opened at $1.35 on Friday. The firm’s 50 day moving average is $1.59 and its two-hundred day moving average is $2.48. The company has a current ratio of 0.94, a quick ratio of 0.64 and a debt-to-equity ratio of 0.19. The firm has a market capitalization of $85.36 million, a P/E ratio of -1.61 and a beta of 0.47. Bioceres Crop Solutions has a 52 week low of $1.20 and a 52 week high of $7.44.

Institutional Investors Weigh In On Bioceres Crop Solutions

Large investors have recently made changes to their positions in the company. Jones Financial Companies Lllp lifted its holdings in shares of Bioceres Crop Solutions by 3,535.8% in the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock valued at $25,000 after purchasing an additional 5,339 shares in the last quarter. Bank of America Corp DE boosted its position in Bioceres Crop Solutions by 186.8% during the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after acquiring an additional 3,735 shares during the period. Virtu Financial LLC purchased a new position in Bioceres Crop Solutions during the 3rd quarter valued at about $40,000. PDT Partners LLC acquired a new position in shares of Bioceres Crop Solutions in the 1st quarter valued at about $81,000. Finally, Avanza Fonder AB lifted its position in shares of Bioceres Crop Solutions by 62.9% in the second quarter. Avanza Fonder AB now owns 26,164 shares of the company’s stock worth $117,000 after purchasing an additional 10,099 shares in the last quarter. Institutional investors and hedge funds own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.